This increase of more than 30% of November 1 is not obtained as a result of news concerning Inventiva, caution, therefore, following the speculators who can in the short term vary the action.
In the long run, I think it's a big possibility if the products work and the tests succeed one after the other. Also, the announcement of an investment fund of a "Call Option" to 12€ before February 2020 is double-edged, a sharp increase is expected and inevitable, a sharp fall if bad news. For me, I bet on a return to 8€ at the end of the year (the same share price as during the introduction) and the passage above 12€ in the first semester of 2020 after the announcement of results (NASH). If bad results, re-fall to very low levels or even abandonment of funds (which own about 20% of the capital), caution ...
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.